KPC Pharmaceuticals,Inc. (SHA:600422)
China
· Delayed Price · Currency is CNY 12.15
-0.01 (-0.08%)
Mar 10, 2026, 3:00 PM CST
KPC Pharmaceuticals,Inc. Revenue
In the year 2025, KPC Pharmaceuticals,Inc. had annual revenue of 6.58B CNY, down -21.72%. KPC Pharmaceuticals,Inc. had revenue of 1.83B in the quarter ending December 31, 2025, a decrease of -37.99%.
Revenue
6.58B
Revenue Growth
-21.72%
P/S Ratio
1.40
Revenue / Employee
1.25M
Employees
5,275
Market Cap
9.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.58B | -1.82B | -21.72% |
| Dec 31, 2024 | 8.40B | -28.73M | -0.34% |
| Dec 31, 2023 | 8.43B | 148.11M | 1.79% |
| Dec 31, 2022 | 8.28B | 28.53M | 0.35% |
| Dec 31, 2021 | 8.25B | 536.45M | 6.95% |
| Jan 1, 2021 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Xianju Pharmaceutical | 3.59B |
| Shandong Lukang Pharmaceutical | 6.19B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.04B |
| Shenzhen Neptunus Bioengineering | 27.28B |
| Jiangsu Yahong Meditech | 277.12M |
| Harbin Pharmaceutical Group | 15.94B |
| North China Pharmaceutical Company.Ltd | 9.79B |
| Tianjin Ringpu Bio-Technology | 3.37B |